These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5858436)

  • 1. The reaction of phenoxymethyl chloromethyl ketone with nitrogen 3 of histidine-57 of chymotrypsin.
    Stevenson KJ; Smillie LB
    J Mol Biol; 1965 Jul; 12(3):937-41. PubMed ID: 5858436
    [No Abstract]   [Full Text] [Related]  

  • 2. The inhibition of chymotrypsin A4 with a homologous series of chloromethyl ketone reagents.
    Stevenson KJ; Smillie LB
    Can J Biochem; 1970 Mar; 48(3):364-75. PubMed ID: 5438324
    [No Abstract]   [Full Text] [Related]  

  • 3. The inhibition of chymotrypsin A4 and B with chloromethyl ketone reagents.
    Stevenson KJ; Smillie LB
    Can J Biochem; 1968 Nov; 46(11):1357-70. PubMed ID: 5687069
    [No Abstract]   [Full Text] [Related]  

  • 4. Further observations on substrate-derived chloromethyl ketones that inactivate trypsin.
    Shaw E; Glover G
    Arch Biochem Biophys; 1970 Aug; 139(2):298-305. PubMed ID: 5533676
    [No Abstract]   [Full Text] [Related]  

  • 5. Subtilisin BPN': inactivation by chloromethyl ketone derivates of peptide substrates.
    Morihara K; Oka T
    Arch Biochem Biophys; 1970 Jun; 138(2):526-31. PubMed ID: 5433587
    [No Abstract]   [Full Text] [Related]  

  • 6. Substrate binding site in bovine chymotrypsin A-gamma. A crystallographic study using peptide chloromethyl ketones as site-specific inhibitors.
    Segal DM; Powers JC; Cohen GH; Davies DR; Wilcox PE
    Biochemistry; 1971 Sep; 10(20):3728-38. PubMed ID: 5107010
    [No Abstract]   [Full Text] [Related]  

  • 7. Kinetics of the reaction of chymotrypsin A with peptide chloromethyl ketones in relation to its subsite specificity.
    Kurachi K; Powers JC; Wilcox PE
    Biochemistry; 1973 Feb; 12(4):771-7. PubMed ID: 4691518
    [No Abstract]   [Full Text] [Related]  

  • 8. Histidine sequences in the active centres of some 'serine' proteinases.
    Smillie LB; Hartley BS
    Biochem J; 1966 Oct; 101(1):232-41. PubMed ID: 5971785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sedimentation of chemically modified chymotrypsin.
    Neet KE; Brydon SE
    Arch Biochem Biophys; 1970 Jan; 136(1):223-7. PubMed ID: 5417619
    [No Abstract]   [Full Text] [Related]  

  • 10. Antigenic determinants in bovine alpha-chymotrypsin.
    Barrett JT; Allen RG
    Prog Immunobiol Stand; 1970; 4():406-10. PubMed ID: 4098274
    [No Abstract]   [Full Text] [Related]  

  • 11. A 13C-n.m.r. investigation of the ionizations within an inhibitor--alpha-chymotrypsin complex. Evidence that both alpha-chymotrypsin and trypsin stabilize a hemiketal oxyanion by similar mechanisms.
    Finucane MD; Hudson EA; Malthouse JP
    Biochem J; 1989 Mar; 258(3):853-9. PubMed ID: 2730570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific modification of methionine-192 of -chymotrypsin by an affinity label exploiting the orienting properties of the linear acetylenic group.
    Jones JB; Hysert DW
    Biochemistry; 1972 Jul; 11(14):2726-33. PubMed ID: 5045526
    [No Abstract]   [Full Text] [Related]  

  • 13. Laser-excited Raman spectroscopy of biomolecules. II. Native ribonuclease and alpha-chymotrypsin.
    Lord RC; Yu NT
    J Mol Biol; 1970 Jul; 51(2):203-13. PubMed ID: 5530393
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence for N to O transfer in the deacylation of an acyl-alpha-chymotrypsin.
    Brocklehurst K; Williamson K
    Biochem Biophys Res Commun; 1967 Jan; 26(2):175-80. PubMed ID: 6030263
    [No Abstract]   [Full Text] [Related]  

  • 15. Alpha-diketone and alpha-keto ester derivatives of N-protected amino acids and peptides as novel inhibitors of cysteine and serine proteinases.
    Angelastro MR; Mehdi S; Burkhart JP; Peet NP; Bey P
    J Med Chem; 1990 Jan; 33(1):11-3. PubMed ID: 2296008
    [No Abstract]   [Full Text] [Related]  

  • 16. Implications of the chemical modification of chymotrypsin.
    Grey SM; Nurse GR; Visser L
    Biochem Biophys Res Commun; 1973 May; 52(2):687-95. PubMed ID: 4736371
    [No Abstract]   [Full Text] [Related]  

  • 17. [Modification of a histidine residue in chymotrypsin by 2-phenyl-1,4-dibromoacetoin].
    Schramm HJ
    Biochem Z; 1965 Jul; 342(2):139-42. PubMed ID: 5867142
    [No Abstract]   [Full Text] [Related]  

  • 18. Methylation of histidine-57 in alpha-chymotrypsin by methyl p-nitrobenzenesulfonate. A new approach to enzyme modification.
    Nakagawa Y; Bender ML
    Biochemistry; 1970 Jan; 9(2):259-67. PubMed ID: 5460940
    [No Abstract]   [Full Text] [Related]  

  • 19. The selective isolation of an active-site histidine peptide from chymotrypsin-alpha by diagonal peptide 'mapping'. An N-tau-carboxymethylhistidine diagonal peptide "mapping.".
    Stevenson KJ
    Biochem J; 1974 Apr; 139(1):215-20. PubMed ID: 4463943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. States of amino acid residues in proteins. 8. Tyrosine, histidine and tryptophan residues in chymotrypsin in the presence of substrate and in diisopropylphosphorylchymotrypsin.
    Hachimori Y; Kurihara K; Horinishi H; Matsushima A; Shibata K
    Biochim Biophys Acta; 1965 Jul; 105(1):167-77. PubMed ID: 5849113
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.